Condition: Aortic Valve Disease Mixed · Sponsor: Xijing Hospital
The purpose of this prospective multi-center, observational registry in China is to collect clinical baseline, procedural, and follow-up data of all patients treated with TAVR in China and to evaluate short-, mid-, and long-term clinical outcome data of all post-marketing transcatheter valves. Each center will collect baseline and procedural data as well as clinical outcomes for up to 10 years.
This description comes directly from the study's public registry record.
Rutao Wang, M.D, Ph.D · +86-15091095796 · rutaowang@qq.com
Ruining Zhang, BSc · +86-15802990370 · ruining-zhang@qq.com
Always discuss trial participation with your own doctor first.
| Ling Tao | Xi'an, Shaanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06257043